SPY326.52+2.56 0.79%
DIA264.35+1.07 0.41%
IXIC10,745.28+157.46 1.49%
News
KTOV
--
0.00%
--
Kitov Pharma launches mid-stage study of NT219 in solid tumors
Seeking Alpha - Article · 07/09 15:32
Kitov Announces Initiation of Phase 1/2 Clinical Trial of NT219 in Advanced Cancer Patients
GlobeNewswire · 07/09 12:30
Kitov Pharma Reports Initiation Of Phase 1/2 Trial Of NT219 In Advanced Cancer Patients
Benzinga · 07/09 11:42
Kitov Pharma Receives Notice of Intention to Grant a European Patent Covering CM24, its anti-CEACAM1 Antibody
GlobeNewswire · 07/08 12:30
Kitov Pharma +18% on new European patent for anti-CEACAM1 antibody
Seeking Alpha - Article · 07/08 12:05
Kitov Pharma Receives Notice Of Intention To Grant A European Patent Covering CM24, Its Anti-CEACAM1 Antibody
Patent coverage for CM24 now extends to the U.S. and the EU TEL AVIV, Israel, July 08, 2020 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. (“Kitov”) (NASDAQ/TASE: KTOV), a clinical-stage company advancing
Benzinga · 07/08 11:32
Ties With Merck Could Explain Kitov's Market Interest
Seeking Alpha - Article · 07/07 02:12
Kitov Pharma's strong cash balance
Seeking Alpha - Article · 07/02 15:23
Kitov Pharma Issues CEO Shareholder Letter Providing Business Update
GlobeNewswire · 07/02 13:34
UPDATE: Kitov Pharma Sees Milestone, Royalty Sales Of 2020 Through 2022 $28M-$36M
Benzinga · 07/02 12:42
Kitov Pharma Issues CEO Letter To Shareholders
Kitov Pharma Issues CEO Shareholder Letter Providing Business Update   • Emerging oncology pipeline continues to advance • Strong balance sheet with over $60M in
Benzinga · 07/02 12:36
TTOO, MMLP, INO and BLNK among midday movers
Seeking Alpha - Article · 07/01 16:43
CHMA, WKHS among premarket losers
Seeking Alpha - Article · 07/01 12:10
GNW, IIPR among premarket losers
Seeking Alpha - Article · 06/30 12:15
The Daily Biotech Pulse: Verrica Flags Potential Regulatory Delay, Back-To-Back FDA Approvals For Merck's Keytruda, OncoCyte Stalls Lung Nodule Malignancy Test
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 29)
Benzinga · 06/30 11:41
NKLA, COTY among premarket gainers
Seeking Alpha - Article · 06/29 12:24
The Daily Biotech Pulse: Chiasma, Heron Await FDA Decisions, DBV Restructures, 3 Biopharmas Make Wall Street Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 25)
Benzinga · 06/26 12:28
Kitov Closes $35.0 Million Registered Direct Offering
GlobeNewswire · 06/25 21:30
Urban One: Anatomy Of A Stock Bubble
Seeking Alpha - Article · 06/24 18:23
Kitov Announces $35.0 Million Registered Direct Offering
GlobeNewswire · 06/23 18:20